The sentinel node biopsy has not come of age (cover page).

The sentinel node biopsy has not come of age (cover page). Br J Dermatol. 2019 Sep 19;: Authors: Sladden M, Zagarella S, Popescu C, Bigby M Abstract We are stunned that Dr Jane McGregor believes that "The sentinel node biopsy (SLNB) has come of age" [1]. We do not accept this claim. SLNB is still younger and less experienced than the pathological criteria of Breslow thickness and ulceration. SLNB provides no survival benefit for melanoma patients [2] and results in complications, including 6% risk of lymphoedema [2]. The vast majority of melanoma patients have negative SLNB and cannot possibly benefit from the procedure. PMID: 31536641 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31536641?dopt=Abstract

Source: The British Journal of Dermatology - September 18, 2019 Category: Dermatology Authors: Sladden M, Zagarella S, Popescu C, Bigby M Tags: Br J Dermatol Source Type: research